Independent Research set a €54.00 ($64.29) price objective on Carl Zeiss Meditec (ETR:AFX) in a report issued on Friday. The brokerage currently has a neutral rating on the stock.

A number of other brokerages have also recently commented on AFX. Berenberg Bank set a €48.00 ($57.14) price target on Carl Zeiss Meditec and gave the stock a buy rating in a research report on Friday. Commerzbank set a €42.00 ($50.00) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research note on Friday. Deutsche Bank set a €40.00 ($47.62) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research note on Friday, December 1st. set a €52.00 ($61.90) price objective on Carl Zeiss Meditec and gave the company a buy rating in a research note on Friday, November 10th. Finally, DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research note on Thursday, October 19th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of €48.07 ($57.23).

Carl Zeiss Meditec (ETR:AFX) opened at €52.14 ($62.07) on Friday. Carl Zeiss Meditec has a 52 week low of €31.44 ($37.43) and a 52 week high of €52.83 ($62.89).

TRADEMARK VIOLATION WARNING: This news story was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://theolympiareport.com/2017/12/12/independent-research-analysts-give-carl-zeiss-meditec-afx-a-54-00-price-target.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with Analyst Ratings Network's FREE daily email newsletter.